Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens T Siveke

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Gastroenterology|August 30, 2014
The increasing diversity of KRAS signaling in pancreatic cancerJens T Siveke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2018
Fibroblast-Activating Protein: Targeting the Roots of the Tumor MicroenvironmentJens T Siveke
American Journal of Medical Genetics. Part A|November 11, 2003
Evidence for systemic manifestations in cerebroretinal vasculopathyJens T Siveke, Holger Schmid
Wiener Medizinische Wochenschrift (1946)|November 21, 2013
Approach to cystic lesions of the pancreasRoland M Schmid, Jens T Siveke
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 6, 2021
[Multimodal treatment of periampullary carcinoma]Timm M Reißig, Jens T Siveke
Gut|October 15, 2015
Next-generation metabolic imaging in pancreatic cancerRickmer F Braren, Jens T Siveke
Cancer Cell|May 17, 2005
Chromosomal instability in mouse metastatic pancreatic cancer--it's Kras and Tp53 after allJens T Siveke, Roland M Schmid
Gut|August 30, 2011
Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncologyPawel K Mazur, Jens T Siveke
Oncotarget|November 24, 2012
KRAS above and beyond - EGFR in pancreatic cancerJens T Siveke, Howard C Crawford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Critical appraisal of locoregional failure and systemic disease progression after preoperative chemoradiation of esophageal adenocarcinomaRalf Gertler, Jens T Siveke, Marcus Feith
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Gastroenterology|August 30, 2014
The increasing diversity of KRAS signaling in pancreatic cancerJens T Siveke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2018
Fibroblast-Activating Protein: Targeting the Roots of the Tumor MicroenvironmentJens T Siveke
American Journal of Medical Genetics. Part A|November 11, 2003
Evidence for systemic manifestations in cerebroretinal vasculopathyJens T Siveke, Holger Schmid
Wiener Medizinische Wochenschrift (1946)|November 21, 2013
Approach to cystic lesions of the pancreasRoland M Schmid, Jens T Siveke
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 6, 2021
[Multimodal treatment of periampullary carcinoma]Timm M Reißig, Jens T Siveke
Gut|October 15, 2015
Next-generation metabolic imaging in pancreatic cancerRickmer F Braren, Jens T Siveke
Cancer Cell|May 17, 2005
Chromosomal instability in mouse metastatic pancreatic cancer--it's Kras and Tp53 after allJens T Siveke, Roland M Schmid
Gut|August 30, 2011
Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncologyPawel K Mazur, Jens T Siveke
Oncotarget|November 24, 2012
KRAS above and beyond - EGFR in pancreatic cancerJens T Siveke, Howard C Crawford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Critical appraisal of locoregional failure and systemic disease progression after preoperative chemoradiation of esophageal adenocarcinomaRalf Gertler, Jens T Siveke, Marcus Feith
Pageof 19